Eugene Chung, D.O.
B.A., UT Austin, 1999
D.O., University of North Texas Health Science Center, Texas College of Osteopathic Medicine, 2003
San Antonio Uniformed Services Health Education Consortium, Texas, Pediatric Residency, 2003-2006
Role of erythropoietin in neuroprotection in a mouse model of chronic hypoxia
Amber O'Bryant, Ph.D.
Postdoctoral Researcher II
Amber O’Bryant earned her Ph.D. in Neuroscience from the University of Texas at Austin. At UT, she studied the use of a novel treatment approach, motor cortical stimulation (CS), for stroke-induced functional impairments under Dr. Theresa Jones. Under Dr. Mark Goldberg, she is interested in investigating post-stroke behavioral recovery and its influence on neural activity and plasticity in residual sensorimotor cortex.
Julio Rojas, Ph.D.
Julio C. Rojas graduated valedictorian from the Tecnológico de Monterrey School of Medicine and completed doctoral studies in neuroscience at the University of Texas at Austin. He is the co-developer of the first in vivo toxicological model of Leber’s optic neuropathy, and he provided the first demonstrations of the neuroprotective effects of Paul Ehrlich’s “magic bullet,” methylene blue, in the brain parenchyma. He is the co-author of more than 20 peer-reviewed publications, and the recipient of the 2004 CONACYT’s Scholarship for Graduate Studies Abroad, the 2008 LLILAS E.D. Farmer Fellowship, and the 2012 Alzheimer’s Association Young Research Fellowship. His work at the Neurorepair Lab focuses on the neuroprotective and neurorehab effects of mitochondrial interventions in stroke.